Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Physical Therapy

Why Does Levodopa Stop Working in PSP?

At a Glance

Levodopa stops working in Progressive Supranuclear Palsy (PSP) because tau protein destroys the brain's dopamine receivers. Without these receivers, the brain cannot process the medication. Never stop this medication abruptly, as it can cause a life-threatening withdrawal syndrome.

It can be incredibly frustrating to find a medication that finally eases your symptoms, only to have it stop working. The reason this happens in Progressive Supranuclear Palsy (PSP) comes down to a fundamental biological difference between PSP and Parkinson’s disease [1]. Parkinson’s disease primarily affects the brain cells that produce dopamine. When you take a medication like Levodopa, it replaces that missing dopamine, and your brain is able to use it. PSP, however, goes a step further: it destroys both the dopamine-producing cells and the “receivers” that process dopamine [2]. As these receivers become too damaged, your brain loses the ability to use the medication, and the drug stops working [3].

The “Key and Lock” Problem

To understand why Levodopa fails in PSP, it helps to think of dopamine as a key and the brain’s dopamine receptors as locks.

In Parkinson’s disease, the brain stops making enough keys, but the locks remain perfectly intact. When you take Levodopa, the medication supplies new keys, which easily fit into the existing locks and help your body move smoothly.

In PSP, a harmful buildup of a substance called tau protein destroys both the keys and the locks [2][3]. When you take Levodopa, you are putting plenty of keys into your system, but there are no locks left for them to fit into. Because the medication relies on these locks (postsynaptic receptors) to communicate with the rest of your brain, losing them means the medication can no longer improve your movement [2].

The “Honeymoon” Phase in PSP-Parkinsonism

You might be wondering: if the receivers are damaged, why did the medication work at all in the beginning?

This temporary benefit is especially common in a specific subtype of the disease called PSP-Parkinsonism (PSP-P) [4]. In the early stages of PSP-P, the brain has lost dopamine-producing cells, but it still has enough functioning receivers left to process the medication [5][6]. Because patients with PSP-P often present with symptoms similar to Parkinson’s—and because they respond moderately well to Levodopa at first—they are frequently misdiagnosed with Parkinson’s disease [5][4].

Unfortunately, this initial success is temporary. As the tau protein buildup continues, it rapidly degrades the remaining dopamine receivers [3]. It also spreads to other non-dopaminergic pathways (areas of the brain that control movement but do not rely on dopamine) [2]. Once the disease progresses beyond the dopamine system, Levodopa loses its effectiveness, and symptoms become resistant to the drug [2][3].

CRITICAL SAFETY WARNING: Do Not Stop Medication Abruptly

Never stop taking Levodopa or change your dosage on your own, even if you feel it is no longer working. Abruptly stopping dopamine medications can cause a severe, life-threatening withdrawal complication called Parkinsonism-hyperpyrexia syndrome. If your doctor decides it is time to stop the medication, they will provide a specific, supervised schedule to slowly taper your dose over time to keep you safe.

What This Means for Your Treatment

Having your medication stop working can feel like a devastating step backward. However, it is important to know that this is a biological hallmark of PSP and is not your fault, nor did your body simply build an “immunity” to the drug.

When Levodopa stops improving your overall mobility or balance, your doctor may re-evaluate its use to avoid unnecessary side effects—like nausea or confusion—when there is no longer a physical benefit. However, some patients find that the medication continues to slightly help with rigidity (muscle stiffness) or bradykinesia (slowness of movement), even if it no longer helps with balance or walking [7].

As dopamine medications become less effective, your care team will shift focus away from pills and toward practical, hands-on symptom management. While structured physical activity is still being studied for advanced disease, multidisciplinary rehabilitation remains a cornerstone of care [8][9]. This often includes:

  • Physical therapy to help maintain overall functionality, teach safe walking strategies, and prevent falls [8][9].
  • Occupational therapy to provide practical solutions like grab bars, weighted utensils, or home modifications so you can maintain independence longer.
  • Speech therapy to address reduced tongue strength [10], manage swallowing difficulties, and ensure you can communicate effectively.

Common questions in this guide

Why does Levodopa work at first but then stop in PSP?
In early PSP-Parkinsonism, the brain still has enough functioning dopamine receivers to process Levodopa. However, as tau protein builds up, it destroys these remaining receivers, leaving the medication with no way to communicate with your brain.
What is the difference between Parkinson's disease and PSP regarding dopamine?
Parkinson's disease destroys the brain cells that produce dopamine, but the receivers stay intact. PSP destroys both the dopamine-producing cells and the receivers, which is why dopamine replacement medications like Levodopa eventually fail.
Can I just stop taking Levodopa if it isn't working for my PSP?
No, you should never stop taking Levodopa on your own. Stopping dopamine medications abruptly can cause a severe, life-threatening withdrawal condition called Parkinsonism-hyperpyrexia syndrome. Your doctor must provide a safe schedule to slowly lower your dose.
Are there any symptoms that Levodopa might still help with in advanced PSP?
Even if Levodopa stops improving your balance or walking, it may still provide some minor relief for muscle stiffness (rigidity) or slowness of movement (bradykinesia). Your doctor can help determine if these benefits outweigh any side effects.
How are movement symptoms managed when Levodopa stops working?
Once medications lose their effectiveness, care shifts to practical symptom management. This includes physical therapy for safe walking, occupational therapy for daily independence, and speech therapy for swallowing and communication.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given that my response to Levodopa has changed, should we slowly begin tapering off the medication to reduce side effects, or does it still appear to be helping with my stiffness?
  2. 2.How do we safely test which of my movement symptoms are still responding to Levodopa versus those that are now resistant?
  3. 3.Could my diagnosis be formally updated in my medical records to reflect PSP-P, ensuring future care providers understand why I don't respond to Parkinson's medications?
  4. 4.What specific timeline or schedule should I follow if we decide to slowly reduce my medication dose to avoid withdrawal symptoms?
  5. 5.Can you provide referrals for physical, occupational, and speech therapists who specifically have experience with atypical parkinsonian disorders like PSP?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Converging peripheral blood microRNA profiles in Parkinson's disease and progressive supranuclear palsy.

    Pavelka L, Rauschenberger A, Hemedan A, et al.

    Brain communications 2024; (6(3)):fcae187 doi:10.1093/braincomms/fcae187.

    PMID: 38863572
  2. 2

    Unmasking levodopa resistance in Parkinson's disease.

    Nonnekes J, Timmer MH, de Vries NM, et al.

    Movement disorders : official journal of the Movement Disorder Society 2016; (31(11)):1602-1609 doi:10.1002/mds.26712.

    PMID: 27430479
  3. 3

    Neuronal oscillations of the pedunculopontine nucleus in progressive supranuclear palsy: Influence of levodopa and movement.

    Galazky I, Zaehle T, Sweeney-Reed CM, et al.

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2020; (131(2)):414-419 doi:10.1016/j.clinph.2019.11.033.

    PMID: 31877491
  4. 4

    Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

    Williams DR, de Silva R, Paviour DC, et al.

    Brain : a journal of neurology 2005; (128(Pt 6)):1247-58 doi:10.1093/brain/awh488.

    PMID: 15788542
  5. 5

    Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease.

    Quattrone A, Bianco MG, Antonini A, et al.

    Movement disorders : official journal of the Movement Disorder Society 2022; (37(6)):1272-1281 doi:10.1002/mds.28992.

    PMID: 35403258
  6. 6

    Tau in Atypical Parkinsonisms: A Meta-Analysis of in Vivo PET Imaging Findings.

    Mena AM, Chen R, Graff-Guerrero A, et al.

    Movement disorders clinical practice 2023; (10(12)):1725-1737 doi:10.1002/mdc3.13885.

    PMID: 38094644
  7. 7

    Acute Levodopa Challenge in Atypical Parkinsonism: Comprehensive Analysis of Individual Motor Responses.

    Ye L, Sani SS, Veith Sanches L, et al.

    Brain sciences 2024; (14(10)) doi:10.3390/brainsci14100991.

    PMID: 39452005
  8. 8

    Physiotherapy case reports on three people with progressive supranuclear palsy.

    Mateus M, Castro Caldas A

    Frontiers in aging neuroscience 2023; (15()):1294293 doi:10.3389/fnagi.2023.1294293.

    PMID: 38145087
  9. 9

    Exercise and physical activity for people with Progressive Supranuclear Palsy: a systematic review.

    Slade SC, Finkelstein DI, McGinley JL, Morris ME

    Clinical rehabilitation 2020; (34(1)):23-33 doi:10.1177/0269215519877235.

    PMID: 31559853
  10. 10

    Tongue strength in progressive supranuclear palsy.

    Clark HM, Stierwalt JA, Meade G, et al.

    Parkinsonism & related disorders 2025; (135()):107839 doi:10.1016/j.parkreldis.2025.107839.

    PMID: 40250258

This page is for educational purposes regarding Levodopa use in PSP and does not replace professional medical advice. Never stop taking your medication abruptly without consulting your doctor.

Get notified when new evidence is published on Progressive supranuclear palsy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.